Global Isocitrate Dehydrogenase Inhibitors Market Size, Status and Forecast 2024-2031

Report ID: 934140 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 IDH1 Mutant Medullary Malignant Tumor
        1.2.3 IDH2 Mutant Medullary Malignant Tumor
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 DH Inhibitor
        1.3.3 FLT3 Inhibitor
        1.3.4 Hedgehog Pathway Inhibitor
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Isocitrate Dehydrogenase Inhibitors Market Perspective (2016-2027)
    2.2 Isocitrate Dehydrogenase Inhibitors Growth Trends by Regions
        2.2.1 Isocitrate Dehydrogenase Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Isocitrate Dehydrogenase Inhibitors Historic Market Share by Regions (2016-2021)
        2.2.3 Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2022-2027)
    2.3 Isocitrate Dehydrogenase Inhibitors Industry Dynamic
        2.3.1 Isocitrate Dehydrogenase Inhibitors Market Trends
        2.3.2 Isocitrate Dehydrogenase Inhibitors Market Drivers
        2.3.3 Isocitrate Dehydrogenase Inhibitors Market Challenges
        2.3.4 Isocitrate Dehydrogenase Inhibitors Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Revenue
        3.1.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Revenue (2016-2021)
        3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2016-2021)
    3.2 Global Isocitrate Dehydrogenase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Isocitrate Dehydrogenase Inhibitors Revenue
    3.4 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio
        3.4.1 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase Inhibitors Revenue in 2020
    3.5 Isocitrate Dehydrogenase Inhibitors Key Players Head office and Area Served
    3.6 Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
    3.7 Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Type
    4.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Type (2016-2021)
    4.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2022-2027)

5 Isocitrate Dehydrogenase Inhibitors Breakdown Data by Application
    5.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Application (2016-2021)
    5.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
    6.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type
        6.2.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
        6.2.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
        6.2.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
    6.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application
        6.3.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
        6.3.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
        6.3.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
    6.4 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country
        6.4.1 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
        6.4.2 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
    7.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type
        7.2.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
        7.2.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
        7.2.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
    7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application
        7.3.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
        7.3.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
        7.3.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
    7.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country
        7.4.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
        7.4.2 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
    8.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type
        8.2.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
    8.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application
        8.3.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
    8.4 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region
        8.4.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
    9.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type
        9.2.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
        9.2.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
        9.2.3 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
    9.3 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application
        9.3.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
        9.3.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
        9.3.3 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
    9.4 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country
        9.4.1 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
        9.4.2 Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size (2016-2027)
    10.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type
        10.2.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2027)
    10.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application
        10.3.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2027)
    10.4 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country
        10.4.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 AGIOS
        11.1.1 AGIOS Company Details
        11.1.2 AGIOS Business Overview
        11.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Introduction
        11.1.4 AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.1.5 AGIOS Recent Development
    11.2 Aslan Pharmaceuticals
        11.2.1 Aslan Pharmaceuticals Company Details
        11.2.2 Aslan Pharmaceuticals Business Overview
        11.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Introduction
        11.2.4 Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.2.5 Aslan Pharmaceuticals Recent Development
    11.3 Bayer
        11.3.1 Bayer Company Details
        11.3.2 Bayer Business Overview
        11.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Introduction
        11.3.4 Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.3.5 Bayer Recent Development
    11.4 Beigene
        11.4.1 Beigene Company Details
        11.4.2 Beigene Business Overview
        11.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Introduction
        11.4.4 Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.4.5 Beigene Recent Development
    11.5 Bristol-Myers Squibb
        11.5.1 Bristol-Myers Squibb Company Details
        11.5.2 Bristol-Myers Squibb Business Overview
        11.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Introduction
        11.5.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.5.5 Bristol-Myers Squibb Recent Development
    11.6 Celgene
        11.6.1 Celgene Company Details
        11.6.2 Celgene Business Overview
        11.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Introduction
        11.6.4 Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.6.5 Celgene Recent Development
    11.7 Daiichi Sankyo
        11.7.1 Daiichi Sankyo Company Details
        11.7.2 Daiichi Sankyo Business Overview
        11.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Introduction
        11.7.4 Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.7.5 Daiichi Sankyo Recent Development
    11.8 Philogen S.p.A.
        11.8.1 Philogen S.p.A. Company Details
        11.8.2 Philogen S.p.A. Business Overview
        11.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Introduction
        11.8.4 Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.8.5 Philogen S.p.A. Recent Development
    11.9 Tesaro
        11.9.1 Tesaro Company Details
        11.9.2 Tesaro Business Overview
        11.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Introduction
        11.9.4 Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.9.5 Tesaro Recent Development
    11.10 Tragara/Adastra
        11.10.1 Tragara/Adastra Company Details
        11.10.2 Tragara/Adastra Business Overview
        11.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Introduction
        11.10.4 Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.10.5 Tragara/Adastra Recent Development
    11.11 Tocagen
        11.11.1 Tocagen Company Details
        11.11.2 Tocagen Business Overview
        11.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Introduction
        11.11.4 Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
        11.11.5 Tocagen Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of IDH1 Mutant Medullary Malignant Tumor
    Table 3. Key Players of IDH2 Mutant Medullary Malignant Tumor
    Table 4. Key Players of Others
    Table 5. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2016-2021)
    Table 9. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2022-2027)
    Table 11. Isocitrate Dehydrogenase Inhibitors Market Trends
    Table 12. Isocitrate Dehydrogenase Inhibitors Market Drivers
    Table 13. Isocitrate Dehydrogenase Inhibitors Market Challenges
    Table 14. Isocitrate Dehydrogenase Inhibitors Market Restraints
    Table 15. Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players (2016-2021)
    Table 17. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2020)
    Table 18. Ranking of Global Top Isocitrate Dehydrogenase Inhibitors Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
    Table 22. Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2016-2021)
    Table 26. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Isocitrate Dehydrogenase Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Application (2016-2021)
    Table 30. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. AGIOS Company Details
    Table 63. AGIOS Business Overview
    Table 64. AGIOS Isocitrate Dehydrogenase Inhibitors Product
    Table 65. AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 66. AGIOS Recent Development
    Table 67. Aslan Pharmaceuticals Company Details
    Table 68. Aslan Pharmaceuticals Business Overview
    Table 69. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product
    Table 70. Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 71. Aslan Pharmaceuticals Recent Development
    Table 72. Bayer Company Details
    Table 73. Bayer Business Overview
    Table 74. Bayer Isocitrate Dehydrogenase Inhibitors Product
    Table 75. Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 76. Bayer Recent Development
    Table 77. Beigene Company Details
    Table 78. Beigene Business Overview
    Table 79. Beigene Isocitrate Dehydrogenase Inhibitors Product
    Table 80. Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 81. Beigene Recent Development
    Table 82. Bristol-Myers Squibb Company Details
    Table 83. Bristol-Myers Squibb Business Overview
    Table 84. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product
    Table 85. Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 86. Bristol-Myers Squibb Recent Development
    Table 87. Celgene Company Details
    Table 88. Celgene Business Overview
    Table 89. Celgene Isocitrate Dehydrogenase Inhibitors Product
    Table 90. Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 91. Celgene Recent Development
    Table 92. Daiichi Sankyo Company Details
    Table 93. Daiichi Sankyo Business Overview
    Table 94. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product
    Table 95. Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 96. Daiichi Sankyo Recent Development
    Table 97. Philogen S.p.A. Company Details
    Table 98. Philogen S.p.A. Business Overview
    Table 99. Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 100. Philogen S.p.A. Recent Development
    Table 101. Tesaro Company Details
    Table 102. Tesaro Business Overview
    Table 103. Tesaro Isocitrate Dehydrogenase Inhibitors Product
    Table 104. Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 105. Tesaro Recent Development
    Table 106. Tragara/Adastra Company Details
    Table 107. Tragara/Adastra Business Overview
    Table 108. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product
    Table 109. Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 110. Tragara/Adastra Recent Development
    Table 111. Tocagen Company Details
    Table 112. Tocagen Business Overview
    Table 113. Tocagen Isocitrate Dehydrogenase Inhibitors Product
    Table 114. Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2016-2021) & (US$ Million)
    Table 115. Tocagen Recent Development
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Isocitrate Dehydrogenase Inhibitors Market Share by Type: 2020 VS 2027
    Figure 2. IDH1 Mutant Medullary Malignant Tumor Features
    Figure 3. IDH2 Mutant Medullary Malignant Tumor Features
    Figure 4. Others Features
    Figure 5. Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2020 VS 2027
    Figure 6. DH Inhibitor Case Studies
    Figure 7. FLT3 Inhibitor Case Studies
    Figure 8. Hedgehog Pathway Inhibitor Case Studies
    Figure 9. Others Case Studies
    Figure 10. Isocitrate Dehydrogenase Inhibitors Report Years Considered
    Figure 11. Global Isocitrate Dehydrogenase Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Isocitrate Dehydrogenase Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions: 2020 VS 2027
    Figure 14. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2022-2027)
    Figure 15. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players in 2020
    Figure 16. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue in 2020
    Figure 18. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2016-2021)
    Figure 19. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2022-2027)
    Figure 20. North America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
    Figure 22. North America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
    Figure 23. North America Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
    Figure 24. United States Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
    Figure 28. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
    Figure 29. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
    Figure 30. Germany Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Share by Region (2016-2027)
    Figure 40. China Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
    Figure 48. Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
    Figure 49. Latin America Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
    Figure 50. Mexico Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Share by Country (2016-2027)
    Figure 56. Turkey Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. AGIOS Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 60. Aslan Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 61. Bayer Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 62. Beigene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 64. Celgene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 65. Daiichi Sankyo Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 66. Philogen S.p.A. Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 67. Tesaro Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 68. Tragara/Adastra Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 69. Tocagen Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AGIOS
Aslan Pharmaceuticals
Bayer
Beigene
Bristol-Myers Squibb
Celgene
Daiichi Sankyo
Philogen S.p.A.
Tesaro
Tragara/Adastra
Tocagen
Frequently Asked Questions
Isocitrate Dehydrogenase Inhibitors report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Isocitrate Dehydrogenase Inhibitors report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Isocitrate Dehydrogenase Inhibitors report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports